Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00265629 · ClinicalTrials.gov registry record · Phase 1
RF Ablation of Atrial Fibrillation
A Phase 1 study, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00265629 is a Phase 1 study that has completed, run by C. R. Bard. The registered enrollment target is 20 participants.
The verdict
NCT00265629, a Phase 1 study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is an early feasibility trial designed to demonstrate whether a new ablation device can be used safely and effectively in treating atrial fibrillation. This study is a prospective, nonrandomized, single-arm, multi-center trial to be conducted at a single study site
Interventions
- DEVICE RF catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00265629
The ClinicalTrials.gov registry entry for NCT00265629 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RF catheter ablation is the first listed.
NCT00265629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00265629 about?
NCT00265629 is a clinical study titled "RF Ablation of Atrial Fibrillation". This is an early feasibility trial designed to demonstrate whether a new ablation device can be used safely and effectively in treating atrial fibrillation. This study is a prospective, nonrandomized, single-arm, multi-center trial to be conducted at a single study site
What is the current status of trial NCT00265629?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2005-08. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00265629?
The interventions under investigation include: RF catheter ablation (DEVICE).
Who is sponsoring clinical trial NCT00265629?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.